Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...
at 09:10 Exo Therapeutics Presents Data on Novel Exosite Inhibitors of TBK1 (EXO-TBKi ... at 09:05 Imbrium Therapeutics Completes First Patient Dosed in Phase 2 Study to Evaluate Sunobinop for the ...
Actress Jamie Lee Curtis, The Guardian newspaper, and even the Clifton Suspension Bridge have joined swathes of people deserting Elon Musk's social media site X. Millions have instead joined ...